Grifols SA (GRFS)
7.85
-0.01
(-0.13%)
USD |
NASDAQ |
Jan 07, 16:00
7.87
+0.02
(+0.25%)
After-Hours: 20:00
Grifols Total Assets (Quarterly): 22.65B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Trinity Biotech PLC | 97.45M |
| Akari Therapeutics PLC | 2.734M |
| TC BioPharm (Holdings) PLC | 8.691M |
| Cellectis SA | 395.88M |
| Evaxion Biotech AS | 15.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.73B |
| Shareholders Equity (Quarterly) | 5.975B |
| Current Ratio | 2.260 |
| Net Debt Paydown Yield | 31.04% |